LivaNova (NASDAQ:LIVN) Cut to “Buy” at StockNews.com

StockNews.com downgraded shares of LivaNova (NASDAQ:LIVN) from a strong-buy rating to a buy rating in a report published on Thursday.

LIVN has been the topic of a number of other research reports. Stifel Nicolaus dropped their price objective on LivaNova from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Wednesday, February 26th. Robert W. Baird upped their price target on shares of LivaNova from $55.00 to $61.00 and gave the company an “outperform” rating in a report on Thursday. Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a research report on Wednesday, February 26th. Barclays dropped their target price on shares of LivaNova from $56.00 to $55.00 and set an “equal weight” rating on the stock in a report on Thursday. Finally, Mizuho reduced their target price on shares of LivaNova from $70.00 to $60.00 and set an “outperform” rating for the company in a report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, LivaNova currently has an average rating of “Moderate Buy” and an average price target of $59.17.

LivaNova Trading Down 0.0 %

LivaNova stock opened at $44.06 on Thursday. LivaNova has a 12-month low of $32.48 and a 12-month high of $63.57. The stock has a market capitalization of $2.40 billion, a PE ratio of 104.90 and a beta of 0.84. The firm has a 50 day simple moving average of $37.89 and a 200-day simple moving average of $45.15. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87.

Institutional Trading of LivaNova

Several hedge funds and other institutional investors have recently modified their holdings of the business. UMB Bank n.a. raised its position in LivaNova by 340.5% during the first quarter. UMB Bank n.a. now owns 837 shares of the company’s stock valued at $33,000 after buying an additional 647 shares during the period. CWM LLC grew its stake in LivaNova by 52.3% during the 1st quarter. CWM LLC now owns 871 shares of the company’s stock valued at $34,000 after acquiring an additional 299 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in shares of LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock valued at $70,000 after purchasing an additional 219 shares during the period. Sterling Capital Management LLC lifted its position in shares of LivaNova by 800.6% in the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock worth $75,000 after purchasing an additional 1,441 shares in the last quarter. Finally, Vestcor Inc acquired a new stake in shares of LivaNova during the fourth quarter worth approximately $204,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.